Last week Kærtor Foundation has been present in the “XII Annual Conference of Technological Platforms for Biomedical Research” in Madrid, an event organized by the four platforms with the support of Asociación Española de Bioempresas, FARMAINDUSTRIA and Fenin – Federación Española de Empresas de Tecnología Sanitaria. On Wednesday, Eneko Aldaba Arévalo ( QUIMATRYX ) talked about the I2D2 initiative and on Thursday, our Scientific Director Mabel Loza and Pedro Arenas Barreiro ( GAIN ), gave their views about the constitution of a drug discovery hub in Galicia, during a roundtable chaired by Raquel Yotti, Director of the Institute of Health Carlos III ( ISCIII ), with the participation also of the Center for Research in Molecular Medicine and Chronic Diseases (CiMUS) of the University of Santiago de Compostela and the Health Research Institute of Santiago de Compostela (IDIS)